Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Beyond traditional pharmacology: evaluating phosphodiesterase inhibitors in autism spectrum disorder
    Published on 2024-04-11
    2 years ago
  • AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects
    Published on 2024-04-10
    2 years ago
  • The selective D3Receptor antagonist VK4-116 reverses loss of insight caused by self-administration of cocaine in rats
    Published on 2024-04-06
    2 years ago
  • Author Correction: Sex differences in offspring risk and resilience following 11β-hydroxylase antagonism in a rodent model of maternal immune activation
    Published on 2024-04-05
    2 years ago
  • The rostromedial tegmental nucleus gates fat overconsumption through ventral tegmental area output in male rats
    Published on 2024-04-03
    2 years ago
  • Retraction Note: Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression
    Published on 2024-03-27
    2 years ago
  • Altered excitatory and inhibitory ionotropic receptor subunit expression in the cortical visuospatial working memory network in schizophrenia
    Published on 2024-03-27
    2 years ago
« Previous 1 … 61 62 63 64 65 … 143 Next »
Journal of Psychopharmacology
  • Effects of CYP2D6*4 polymorphism on the steady-state concentration of paroxetine in patients diagnosed with depressive episode and comorbid alcohol use disorder
    Published on 2022-07-21
    3 years ago
  • Clozapine-specific proliferative response of peripheral blood-derived mononuclear cells in Japanese patients with clozapine-induced agranulocytosis
    Published on 2022-07-21
    3 years ago
  • Examining the role of systemic chronic inflammation in diet and sleep relationship
    Published on 2022-07-21
    3 years ago
  • Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression
    Published on 2022-07-21
    3 years ago
  • Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial
    Published on 2022-07-07
    3 years ago
  • The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls
    Published on 2022-06-30
    3 years ago
  • MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial
    Published on 2022-06-21
    3 years ago
« Previous 1 … 61 62 63 64 65 … 134 Next »
European Neuropsychopharmacology
  • Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016
    Published on 2022-11-24
    3 years ago
  • Effect of psychotropics on the risk of COVID-19 in Middle-Aged and Older Adults
    Published on 2022-11-24
    3 years ago
  • Sexual orientation as an important factor in personalized medicine
    Published on 2022-11-14
    3 years ago
  • Single dose S-ketamine rescues transcriptional dysregulation of Mtor and Nrp2 in the prefrontal cortex of FSL rats 1hour but not 14 days post dosing
    Published on 2022-11-12
    3 years ago
  • Delay in pharmacological treatment of autistic children after recognition of the disorder
    Published on 2022-11-11
    3 years ago
  • Ayahuasca’s therapeutic potential: What we know – and what not
    Published on 2022-11-08
    3 years ago
  • Psychiatric vulnerability in animal models
    Published on 2022-11-05
    3 years ago
« Previous 1 … 61 62 63 64 65 … 154 Next »

   Pharma Pub